A WORLD leader in industrial biotechnology – using biological sources to produce materials, chemicals or energy – has secured funding of more than £87,000 to speed up production of therapeutic proteins, the world’s most expensive pharmaceuticals with a £216 billion market.
Ingenza, based at Roslin, Midlothian, won the funding from the Industrial Biotechnology Innovation Centre (IBioIC) for its work with the University of Edinburgh on the laboratory-engineered proteins.
Ian Fotheringham, Ingenza’s managing director, said: “Our growth and success as a pioneering business in Scotland has been supported by IBioIC, which has now invested more than £1.3 million in our collaborative work with [Higher Education Institutes] HEIs in Scotland. This support has helped us to progress research that will ultimately benefit society, academia and business in Scotland, the UK and across the world.”
Ian Archer, IBioIC technical director, added: “Synthetic biology tools are being developed by Scottish Higher Education Institutes (HEIs) across a wide range of organisms such as bacteria, yeast, fungi, plants and animals which could be translated into supporting human health, crop and livestock development.”
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here